Ceftazidime is the active substance of an anti-bacterial medicine known commercially as Fortaz.
This injectable drug acts by destroying the bacterial cell membrane and decreasing the symptoms of the infection and is therefore indicated for the treatment of skin and soft tissue infections, meningitis and pneumonia.
Ceftazidime has a rapid absorption into the body and its excess is excreted in the urine.
Indications for Ceftazidime
Joint infection; skin and soft tissue infection; infection in the abdomen; infection in the bones; women's pelvic infection; urinary infection; meningitis; pneumonia.
Side effects of Ceftazidime
Inflammation in the vein; vein obstruction; Skin rash; urticaria; itching; pain at the injection site; injection site abscess; temperature increase; peeling of the skin.
Contraindications of Ceftazidime
Pregnancy risk B; Women in the lactation phase; individuals allergic to cephalosporins, penicillins and their derivatives.
How to use Ceftazidime
Injectable use
Adults and adolescents
- Urinary tract infection: Apply 250 mg every 12 hours.
- Pneumonia: Apply 500 mg every 8 or 12 hours.
- Infection in bones or joints: Apply 2g (intravenous) every 12 hours.
- Abdominal infection; pelvic or meningitis: Apply 2g (intravenous) every 8 hours.
Children
Meningitis
- Newborns (0 to 4 weeks): Apply 25 to 50 mg of body weight intravenously every 12 hours.
- 1 month to 12 years: 50 mg per kg body weight intravenously every 8 hours.
